Hyperthermic isolated perfusion with low-dose tumor necrosis factor alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcomas.
Journal article published in 2005 by
Rossi Cr,
C. R. Rossi,
S. Mocellin,
P. Pilati,
M. Foletto,
L. Campana,
L. Quintieri,
G. L. De Salvo 
,
De Salvo Gl,
M. Lise
,
De Salvo Gl,
M. Lise
